View web version
The week's top stories
The FDA cites risk info in letter over Contrave DTC ad
The regulator also took issue with how Orexigen Therapeutics presented the risk information
Alexion hires new chief commercial officer
Brian Goff is expected to replace Carsten Thiel in June. The drugmaker said Tuesday that Thiel along with several other execs would be leaving the firm.
Following Tymlos approval, Radius uses Facebook to educate about osteoporosis
The company said adult women between the ages of 50 and 70 are most likely to share content on the social media platform.
Nearly every $100,000 drug approved in the last three years was for a rare disease
This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.
Otsuka, Proteus refile their sensor-enabled drug
The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
The FDA says Puma's breast-cancer drug is effective, cautions about side effects
An FDA advisory committee is expected to decide Wednesday whether to recommend neratinib for approval.
The week in opinion
In Surprising Twist, Trust Rises for Healthcare Companies
By Kym White, Edelman
But will pharma and biotechnology firms be able to advance this year's positive momentum?
How to Shatter the Glass Ceiling
By Sander Flaum, Flaum Navigators
Healthcare marketing has a head start in grooming women leaders. But it's by no means a fait accompli.
Subscribe to MM&M

Medical Marketing & Media offers the most relevant news, analysis, opinion, feature stories and special reports to more than 16,000 marketing executives at pharma companies, agencies, and in healthcare media. Click here to subscribe. 





Advertise
For details on how to advertise in MM&M Weekly Digest, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M Weekly Digest click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
275 7th Avenue, 10th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2017 Haymarket Media Inc.